Myocardial Viability Imaging: Does It Still Have a Role in Patient Selection Prior to Coronary Revascularisation

Suchi Grover, Govindarajan Srinivasan, Joseph Selvanayagam

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    Patients with severe left ventricular (LV) dysfunction and multi-vessel coronary artery disease (CAD) are at high risk during revascularisation, however they are also likely to derive the most benefit. Historically, the detection of dysfunctional but potentially viable myocardium ('stunned or hibernating myocardium') has been central to the decision-making regarding revascularisation. A number of recent studies have challenged this paradigm, questioning the role of viability testing in this population. In this review, we will examine the position of viability testing and how it is best incorporated in the modern era of coronary revascularisation. We will outline the role of currently available imaging modalities in viability assessment. Myocardial viability testing will continue to play a role in revascularisation decisions, although larger randomised trials with clinical outcome end-points are needed to further define its role.

    Original languageEnglish
    Pages (from-to)469-479
    Number of pages11
    JournalHeart, Lung and Circulation
    Volume21
    Issue number8
    DOIs
    Publication statusPublished - 2012

    Fingerprint Dive into the research topics of 'Myocardial Viability Imaging: Does It Still Have a Role in Patient Selection Prior to Coronary Revascularisation'. Together they form a unique fingerprint.

  • Cite this